Terms: = Lymphoma AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L
177 results:
1. Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
[TBL] [Abstract] [Full Text] [Related]
2. Anaplastic large cell lymphoma presenting as a mass in the uterine cervix: a case report.
Mingola P; Alshomrani A; Greiner T
J Hematop; 2024 Mar; 17(1):23-26. PubMed ID: 38376721
[TBL] [Abstract] [Full Text] [Related]
3. Genetic Characterization of Primary Mediastinal B-Cell lymphoma: Pathogenesis and Patient Outcomes.
Noerenberg D; Briest F; Hennch C; Yoshida K; Hablesreiter R; Takeuchi Y; Ueno H; Staiger AM; Ziepert M; Asmar F; Locher BN; Toth E; Weber T; Amini RM; Klapper W; Bouzani M; Poeschel V; Rosenwald A; Held G; Campo E; Ishaque N; Stamatopoulos K; Kanellis G; Anagnostopoulos I; Bullinger L; Goldschmidt N; Zinzani PL; Bödör C; Rosenquist R; Vassilakopoulos TP; Ott G; Ogawa S; Damm F
J Clin Oncol; 2024 Feb; 42(4):452-466. PubMed ID: 38055913
[TBL] [Abstract] [Full Text] [Related]
4. tp63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence.
Wu G; Yoshida N; Liu J; Zhang X; Xiong Y; Heavican-Foral TB; Mandato E; Liu H; Nelson GM; Yang L; Chen R; Donovan KA; Jones MK; Roshal M; Zhang Y; Xu R; Nirmal AJ; Jain S; Leahy C; Jones KL; Stevenson KE; Galasso N; Ganesan N; Chang T; Wu WC; Louissaint A; Debaize L; Yoon H; Dal Cin P; Chan WC; Ho Sui SJ; Ng SY; Feldman AL; Horwitz SM; Adelman K; Fischer ES; Chen CW; Weinstock DM; Brown M
Sci Transl Med; 2023 Sep; 15(714):eadi7244. PubMed ID: 37729434
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic factors for primary cutaneous anaplastic large-cell lymphoma: a multicentre retrospective study from Japan.
Miyagaki T; Inoue N; Kamijo H; Boki H; Takahashi-Shishido N; Suga H; Shimauchi T; Kiyohara E; Hirai Y; Yonekura K; Takeuchi K; Sugaya M
Br J Dermatol; 2023 Oct; 189(5):612-620. PubMed ID: 37539944
[TBL] [Abstract] [Full Text] [Related]
6. Rearrangement of
Othman BK; Steiner P; Leivo I; Skálová A
Fetal Pediatr Pathol; 2023 Oct; 42(5):796-807. PubMed ID: 37517063
[No Abstract] [Full Text] [Related]
7. Primary cutaneous gamma/delta T-cell lymphoma with simultaneous JAK2 and tp63 rearrangements: a new double-hit?
Fadl A; Bennani NN; Comfere N; Durani U; Greipp PT; Feldman AL
Histopathology; 2023 Sep; 83(3):492-495. PubMed ID: 37308177
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Significance of p53 and p63 in Diffuse Large B-Cell lymphoma: A Single-Institution Experience.
Moreno JCA; Bahmad HF; Aljamal AA; Delgado R; Salami A; Guillot C; Castellano-Sánchez AA; Medina AM; Sriganeshan V
Curr Oncol; 2023 Jan; 30(2):1314-1331. PubMed ID: 36826063
[TBL] [Abstract] [Full Text] [Related]
9. ALK-negative anaplastic large cell lymphoma with
Sibon D; Bisig B; Bonnet C; Poullot E; Bachy E; Cavalieri D; Fataccioli V; Bregnard C; Drieux F; Bruneau J; Lemonnier F; Dupuy A; Bossard C; Parrens M; Bouabdallah K; Ketterer N; Berthod G; Cairoli A; Damaj G; Tournilhac O; Jais JP; Gaulard P; De Leval L
Haematologica; 2023 Jun; 108(6):1590-1603. PubMed ID: 36453105
[TBL] [Abstract] [Full Text] [Related]
10.
Qiu L; Tang G; Li S; Vega F; Lin P; Wang SA; Wang W; Iyer SP; Malpica L; Miranda RN; Konoplev S; Tang Z; Fang H; Medeiros LJ; Xu J
Haematologica; 2023 Jun; 108(6):1604-1615. PubMed ID: 36453104
[TBL] [Abstract] [Full Text] [Related]
11. Clinical and Radiographic Predictors of Progression and Survival in Relapsed/Refractory lymphoma Patients Receiving Anti-CD19 CAR T-cell Therapy.
Jodon G; Colton MD; Abbott D; Cai A; Haverkos B; Morgan R; Kamdar M
Clin Lymphoma Myeloma Leuk; 2023 Jan; 23(1):49-56. PubMed ID: 36335021
[TBL] [Abstract] [Full Text] [Related]
12. Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell lymphoma.
Feldman AL; Oishi N; Ketterling RP; Ansell SM; Shi M; Dasari S
Am J Surg Pathol; 2022 Nov; 46(11):1490-1499. PubMed ID: 35941721
[TBL] [Abstract] [Full Text] [Related]
13. Primary pulmonary epithelial-myoepithelial carcinoma: Report of a rare and under-diagnosed low-grade malignancy.
Sharma S; Tayal A; Khatri S; Mohapatra SG; Mohanty SK
J Cancer Res Ther; 2022; 18(3):795-800. PubMed ID: 35900560
[TBL] [Abstract] [Full Text] [Related]
14. Primary ALK-Negative
Ching D; Chiu SK; Van Vliet C; Jasim A
Int J Surg Pathol; 2023 Aug; 31(5):612-615. PubMed ID: 35898185
[TBL] [Abstract] [Full Text] [Related]
15. Immunomolecular Investigation of Human Papillomavirus Genotypes (16, 18) and p63 Expression in Patients with Malignant and Non-malignant Colorectal Tumors.
Kadhem Mallakh M; Mohammed Mahmood M; Hasan Mohammed Ali S
Arch Razi Inst; 2022 Feb; 77(1):383-390. PubMed ID: 35891769
[TBL] [Abstract] [Full Text] [Related]
16. Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement.
Fratoni S; Trawinska MM; Capalbo A; Bernardini L; Fabbretti M; Martini M; Niscola P; Zhao XF
Virchows Arch; 2022 Dec; 481(6):975-979. PubMed ID: 35879438
[TBL] [Abstract] [Full Text] [Related]
17. TCF3 protein was highly expressed in pediatric Burkitt lymphoma and predicts poor prognosis: a single-center study.
Man J; Wang H; Qian X; Chen L; Ma Y; Qian M; Zhai X
Leuk Lymphoma; 2022 Oct; 63(10):2453-2460. PubMed ID: 35617527
[TBL] [Abstract] [Full Text] [Related]
18. Diverse tumorigenic consequences of human papillomavirus integration in primary oropharyngeal cancers.
Symer DE; Akagi K; Geiger HM; Song Y; Li G; Emde AK; Xiao W; Jiang B; Corvelo A; Toussaint NC; Li J; Agrawal A; Ozer E; El-Naggar AK; Du Z; Shewale JB; Stache-Crain B; Zucker M; Robine N; Coombes KR; Gillison ML
Genome Res; 2022 Jan; 32(1):55-70. PubMed ID: 34903527
[TBL] [Abstract] [Full Text] [Related]
19. ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells.
Van Sciver N; Ohashi M; Nawandar DM; Pauly NP; Lee D; Makielski KR; Bristol JA; Tsao SW; Lambert PF; Johannsen EC; Kenney SC
PLoS Pathog; 2021 Nov; 17(11):e1010045. PubMed ID: 34748616
[TBL] [Abstract] [Full Text] [Related]
20. [Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma].
Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
[No Abstract] [Full Text] [Related]
[Next]
